This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.
Subscribe to the Daily Journal for access to Daily Appellate Reports, Verdicts, Judicial Profiles and more...

Sep. 13, 2009

Delivering Treatments, One Contract at a Time

Gilead Sciences’ Brett Pletcher oversees efforts to sell medicine where it is needed the most.

Read more about Brett Pletcher...

Some 30 million of the 33 million people worldwide infected with human immunodeficiency virus are in low- and middle-income nations, and two-thirds are in sub-Saharan Africa.

Gilead Sciences Inc., the Foster City-based biopharmaceutical company that manufactures several of the world's key drugs for fighting HIV infection, is thus fundamentally global. When the company gained U.S. Food and Drug Administration approval for its HIV drug Viread in 2001, it did so ami... (continued)

To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
$795 for an entire year!

Already a subscriber?